{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:24:45Z","timestamp":1793759085528,"version":"4.6.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G0A3G25N"],"award-info":[{"award-number":["G0A3G25N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["11P1T24N"],"award-info":[{"award-number":["11P1T24N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["11L5124N"],"award-info":[{"award-number":["11L5124N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1S73019N"],"award-info":[{"award-number":["1S73019N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G023320N"],"award-info":[{"award-number":["G023320N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["11P3024N"],"award-info":[{"award-number":["11P3024N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Flanders Innovation &amp; Entrepreneurship","doi-asserted-by":"publisher","award":["HBC.2023.0149"],"award-info":[{"award-number":["HBC.2023.0149"]}],"id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118522","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T19:34:08Z","timestamp":1757014448000},"page":"118522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Phenylketonuria: A guide through the complex maze of its neurological pathophysiology providing a new perspective on treatment strategies"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-1340","authenticated-orcid":false,"given":"Ine","family":"Nulmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien","family":"Lequeue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigly G.","family":"Del\u2019haye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina S.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rombaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Neuckermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joery","family":"De Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118522_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2025.118522_bib2","first-page":"59","article-title":"Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan","volume":"55","author":"Carducci","year":"2020","journal-title":"JIMD Rep."},{"key":"10.1016\/j.biopha.2025.118522_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118522_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183430","article-title":"Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuria","volume":"12","author":"Fiori","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118522_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13023-021-01874-6","article-title":"Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis","volume":"16","author":"Foreman","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201489","article-title":"Molecular-genetic causes for the high frequency of phenylketonuria in the population from the north Caucasus","volume":"13","author":"Gundorova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118522_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/bchm2.1934.227.1-4.169","article-title":"\u00dcber ausscheidung von Phenylbrenztraubens\u00e4ure in den harn als stoffwechselanomalie in verbindung mit Imbezillit\u00e4t","volume":"227","author":"F\u00f6lling","year":"1934","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.biopha.2025.118522_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1651-2227.1994.tb13440.x","article-title":"The discovery of phenylketonuria","volume":"83","author":"F\u00f8lling","year":"1994","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.biopha.2025.118522_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopha.2025.118522_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key european guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2025.118522_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","article-title":"Phenylketonuria scientific review conference: state of the science and future research needs","volume":"112","author":"Camp","year":"2014","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/abio.370040210","article-title":"Rechnergest\u00fctzte F\u00fchrung von fermentationsprozessen, teil 2","volume":"4","author":"Prause","year":"1984","journal-title":"Acta Biotechnol."},{"key":"10.1016\/j.biopha.2025.118522_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-015-0378-7","article-title":"Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile","volume":"10","author":"Pena","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/bcp.13886","article-title":"Efficacy and safety of sapropterin dihydrochloride in patients with phenylketonuria: a meta-analysis of randomized controlled trials","volume":"85","author":"Qu","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118522_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118522_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2011.03.020","article-title":"Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study","volume":"103","author":"Burton","year":"2011","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2019.07.018","article-title":"Long-term comparative effectiveness of pegvaliase versus standard of care comparators in adults with phenylketonuria","volume":"128","author":"Zori","year":"2019","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib19","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41436-018-0403-z","article-title":"Evidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria","volume":"21","author":"Longo","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10545-006-0395-8","article-title":"Large neutral amino acids in the treatment of phenylketonuria (PKU)","volume":"29","author":"Matalon","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/nu12041092","article-title":"Large neutral amino acids (LNAAs) supplementation improves neuropsychological performances in adult patients with phenylketonuria","volume":"12","author":"Scala","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118522_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143833","article-title":"Large neutral amino acid supplementation exerts its effect through three synergistic mechanisms: proof of principle in phenylketonuria mice","volume":"10","author":"van Vliet","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118522_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.155116","article-title":"PTC923 (sepiapterin) lowers elevated blood phenylalanine in subjects with phenylketonuria: a phase 2 randomized, multi-center, three-period crossover, open-label, active controlled, all-comers study","volume":"128","author":"Bratkovic","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2025.118522_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ymgme.2019.02.001","article-title":"Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers","volume":"126","author":"Smith","year":"2019","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib25","unstructured":"European Medicines Agency. Sephience. European Medicines Agency (2025)."},{"key":"10.1016\/j.biopha.2025.118522_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jimd.12651","article-title":"State-of-the-art 2023 on gene therapy for phenylketonuria","volume":"47","author":"Martinez","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib27","article-title":"Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation","author":"Vonada","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2025.118522_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.993298","article-title":"Phenylalanine hydroxylase mRNA rescues the phenylketonuria phenotype in mice","volume":"10","author":"Cacicedo","year":"2022","journal-title":"Front Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118522_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete european guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2022.03.012","article-title":"Phenylketonuria oxidative stress and energy dysregulation: emerging pathophysiological elements provide interventional opportunity","volume":"136","author":"Dobrowolski","year":"2022","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymgme.2022.03.004","article-title":"Comparative metabolomics in the Pahenu2 classical PKU mouse identifies cerebral energy pathway disruption and oxidative stress","volume":"136","author":"Dobrowolski","year":"2022","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymgme.2020.12.001","article-title":"Inter- and intra-tract analysis of White matter abnormalities in individuals with early-treated phenylketonuria (PKU)","volume":"132","author":"Clocksin","year":"2021","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00415-019-09608-2","article-title":"Neurological manifestations in adults with phenylketonuria: new cases and review of the literature","volume":"267","author":"Jaulent","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2025.118522_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.spen.2016.11.007","article-title":"Impaired neurotransmission in Early-treated phenylketonuria patients","volume":"23","author":"Gonz\u00e1lez","year":"2016","journal-title":"Semin Pedia Neurol."},{"key":"10.1016\/j.biopha.2025.118522_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14336\/AD.2015.0827","article-title":"Phenylketonuria pathophysiology: on the role of metabolic alterations","volume":"6","author":"Schuck","year":"2015","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria","volume":"103","author":"Pietz","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118522_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ymgme.2021.09.004","article-title":"Correlations of blood and brain biochemistry in phenylketonuria: results from the Pah-enu2 PKU mouse","volume":"134","author":"Dijkstra","year":"2021","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib39","article-title":"Phenylketonuria: modelling cerebral amino acid and neurotransmitter metabolism","author":"Wegrzyn","year":"2024","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2025.118522_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymgme.2015.11.012","article-title":"High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU)","volume":"117","author":"Winn","year":"2016","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainres.2008.04.006","article-title":"Reduced availability of brain amines during critical phases of postnatal development in a genetic mouse model of cognitive delay","volume":"1217","author":"Pascucci","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2025.118522_bib42","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ymgme.2009.10.007","article-title":"Executive function in early-treated phenylketonuria: profile and underlying mechanisms","volume":"99","author":"Christ","year":"2010","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib43","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1017\/S0033291717001398","article-title":"Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria","volume":"47","author":"Boot","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1037\/0894-4105.17.3.369","article-title":"Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria","volume":"17","author":"Huijbregts","year":"2003","journal-title":"Neuropsychology"},{"key":"10.1016\/j.biopha.2025.118522_bib45","series-title":"The Prefrontal Cortex","first-page":"9","article-title":"Anatomy of the prefrontal cortex","author":"Fuster","year":"2015"},{"key":"10.1016\/j.biopha.2025.118522_bib46","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10545-012-9473-2","article-title":"In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria","volume":"35","author":"Pascucci","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib47","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/00001756-200004270-00042","article-title":"Dramatic brain aminergic deficit in a genetic mouse model of phenylketonuria","volume":"11","author":"Puglisi-Allegra","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopha.2025.118522_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2013.07.022","article-title":"Dopamine D3 receptor as a new pharmacological target for the treatment of depression","volume":"719","author":"Leggio","year":"2013","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118522_bib49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13803395.2019.1696753","article-title":"Emotional health in early-treated adults with phenylketonuria (PKU): relationship with cognitive abilities and blood phenylalanine","volume":"42","author":"Palermo","year":"2020","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.biopha.2025.118522_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2017.10.009","article-title":"Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice","volume":"123","author":"Winn","year":"2018","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cercor\/bhj120","article-title":"Cognitive inflexibility after prefrontal serotonin depletion is behaviorally and neurochemically specific","volume":"17","author":"Clarke","year":"2006","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biopha.2025.118522_bib52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1517\/13543780902880850","article-title":"Current investigational drugs for major depression","volume":"18","author":"Kulkarni","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.biopha.2025.118522_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118522_bib54","first-page":"1","article-title":"Epilepsy and dopaminergic system","volume":"21","author":"Rezaei","year":"2017","journal-title":"Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118522_bib55","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses\u2606","volume":"99","author":"de Groot","year":"2010","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105629","article-title":"The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders","volume":"171","author":"Szigetvari","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118522_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106952","article-title":"Possible role of tryptophan metabolism along the microbiota-gut-brain axis on cognitive & behavioral aspects in phenylketonuria","volume":"197","author":"Parolisi","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ymgme.2015.04.002","article-title":"Altered DNA methylation in PAH deficient phenylketonuria","volume":"115","author":"Dobrowolski","year":"2015","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.32607\/actanaturae.11043","article-title":"DNA methylation as an epigenetic mechanism in the development of multiple sclerosis","volume":"13","author":"Kiselev","year":"2021","journal-title":"Acta Nat."},{"key":"10.1016\/j.biopha.2025.118522_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"microRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02267-2","article-title":"Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria","volume":"11","author":"Manek","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118522_bib63","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/jnc.12683","article-title":"Altered brain protein expression profiles are associated with molecular neurological dysfunction in the <scp>PKU<\/scp> mouse model","volume":"129","author":"Imperlini","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118522_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/syn.20740","article-title":"Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epilepsy","volume":"64","author":"Lakhan","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.biopha.2025.118522_bib65","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1007\/s12035-019-1568-4","article-title":"Dysregulation of CRMP2 Post-Translational modifications drive its pathological functions","volume":"56","author":"Moutal","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118522_bib66","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2009.11.042","article-title":"Behavioral and neurochemical characterization of mice deficient in the N-type Ca2+ channel \u03b11B subunit","volume":"208","author":"Nakagawasai","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2025.118522_bib67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00424-018-02248-x","article-title":"Four novel interaction partners demonstrate diverse modulatory effects on voltage-gated CaV2.2 Ca2+ channels","volume":"471","author":"Mallmann","year":"2019","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2025.118522_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-020-02244-5","article-title":"Intellectual disability: dendritic anomalies and emerging genetic perspectives","volume":"141","author":"Quach","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2025.118522_bib69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1096\/fj.07-9012com","article-title":"CRMP3 is required for hippocampal ca1 dendritic organization and plasticity","volume":"22","author":"Quach","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.118522_bib70","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41580-023-00668-x","article-title":"Mechanisms of SNARE proteins in membrane fusion","volume":"25","author":"Jahn","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib71","doi-asserted-by":"crossref","first-page":"10471","DOI":"10.1073\/pnas.93.19.10471","article-title":"SNAP-25 and synaptotagmin involvement in the final Ca(2+)-dependent triggering of neurotransmitter exocytosis","volume":"93","author":"Mehta","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118522_bib72","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/cdd.2014.227","article-title":"Reduced SNAP-25 increases PSD-95 mobility and impairs spine morphogenesis","volume":"22","author":"Fossati","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2025.118522_bib73","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2025.118522_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","article-title":"The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis","volume":"9","author":"Kaushansky","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2025.118522_bib75","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1523\/JNEUROSCI.0420-19.2020","article-title":"Twenty years of SynGAP research: from synapses to cognition","volume":"40","author":"Gamache","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118522_bib76","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/epi.17336","article-title":"Molecular and clinical descriptions of patients with <scp> GABA a <\/scp> receptor gene variants ( <scp>GABRA1<\/scp>, <scp>GABRB2<\/scp>, <scp>GABRB3<\/scp>, <scp>GABRG2<\/scp>): a cohort study, review of literature, and genotype\u2013phenotype correlation","volume":"63","author":"Maillard","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopha.2025.118522_bib77","series-title":"Encyclopedia of Biological Chemistry III","first-page":"732","article-title":"Lipids | cholesterol synthesis and regulation","author":"Shao","year":"2021"},{"key":"10.1016\/j.biopha.2025.118522_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1041961","article-title":"Overview of myelin, major myelin lipids, and myelin-associated proteins","volume":"10","author":"Kister","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2025.118522_bib79","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118522_bib80","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118522_bib81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2017.05.004","article-title":"Cytochrome P450 eicosanoids in cerebrovascular function and disease","volume":"179","author":"Davis","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118522_bib82","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaa061","article-title":"The PEP-pyruvate-oxaloacetate node: variation at the heart of metabolism","volume":"45","author":"Koendjbiharie","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.biopha.2025.118522_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymben.2019.01.001","article-title":"Pyruvate kinase L\/R is a regulator of lipid metabolism and mitochondrial function","volume":"52","author":"Liu","year":"2019","journal-title":"Metab. Eng."},{"key":"10.1016\/j.biopha.2025.118522_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/7702681","article-title":"The role of PKM2 in the regulation of mitochondrial function: focus on mitochondrial metabolism, oxidative stress, dynamic, and apoptosis. Pkm2 in mitochondrial function","volume":"2022","author":"Gao","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2025.118522_bib85","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib86","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1074\/jbc.M609367200","article-title":"Nuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species production","volume":"282","author":"Gusdon","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118522_bib87","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3109\/19401736.2015.1060417","article-title":"Whole mitochondrial genome analysis in two families with dilated mitochondrial cardiomyopathy: detection of mutations in mt-nd2 and mt-tl1 genes","volume":"27","author":"Alila","year":"2016","journal-title":"Mitochondrial DNA Part A"},{"key":"10.1016\/j.biopha.2025.118522_bib88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tem.2019.02.002","article-title":"ACMSD: a novel target for modulating NAD+ homeostasis","volume":"30","author":"Yoshino","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib89","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.celrep.2018.09.091","article-title":"Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde decarboxylase controls dietary niacin requirements for NAD+ synthesis","volume":"25","author":"Palzer","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118522_bib90","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.009183","article-title":"Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice","author":"Jones","year":"2012","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2025.118522_bib91","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.febslet.2012.05.059","article-title":"4E-BP3 regulates eIF4E-mediated nuclear mRNA export and interacts with replication protein A2","volume":"586","author":"Chen","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2025.118522_bib92","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s12035-021-02304-1","article-title":"Insights from animal models on the pathophysiology of hyperphenylalaninemia: role of mitochondrial dysfunction, oxidative stress and inflammation","volume":"58","author":"Wyse","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118522_bib93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11011-021-00676-w","article-title":"Oxidative stress in phenylketonuria\u2014evidence from human studies and animal models, and possible implications for redox signaling","volume":"36","author":"Bortoluzzi","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib94","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/pcmr.12393","article-title":"Melanins and melanogenesis: from pigment cells to human health and technological applications","volume":"28","author":"d\u2019Ischia","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2025.118522_bib95","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13346-023-01392-x","article-title":"Effects of arginine on coenzyme-Q10 micelle uptake for mitochondria-targeted nanotherapy in phenylketonuria","volume":"14","author":"Uner","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib96","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1515\/jpem-2018-0454","article-title":"Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients","volume":"32","author":"Kumru","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuint.2018.01.001","article-title":"Brain bioenergetics in rats with acute hyperphenylalaninemia","volume":"117","author":"Dimer","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2025.118522_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1001115","article-title":"Reactive oxygen species production by forward and reverse electron fluxes in the mitochondrial respiratory chain","volume":"7","author":"Selivanov","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib99","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10571-010-9636-3","article-title":"Evidence that l-Carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients","volume":"31","author":"Sitta","year":"2011","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118522_bib100","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.3390\/jcm12185796","article-title":"L-Carnitine and Male fertility: is supplementation beneficial?","volume":"12","author":"Mateus","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib101","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1475-2891-13-79","article-title":"Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial","volume":"13","author":"Lee","year":"2014","journal-title":"Nutr. J."},{"key":"10.1016\/j.biopha.2025.118522_bib102","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ymgme.2013.09.009","article-title":"Micronutrient status in phenylketonuria","volume":"110","author":"Robert","year":"2013","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s12011-013-9724-6","article-title":"Controlled diet in phenylketonuria and hyperphenylalaninemia May cause serum selenium deficiency in adult patients: the Czech experience","volume":"154","author":"Proch\u00e1zkov\u00e1","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib104","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12199-007-0019-4","article-title":"Selenium: its role as antioxidant in human health","volume":"13","author":"Tinggi","year":"2008","journal-title":"Environ. Health Prev. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbabio.2008.04.011","article-title":"Regulation of glycolysis and pentose\u2013phosphate pathway by nitric oxide: impact on neuronal survival","volume":"1777","author":"Bola\u00f1os","year":"2008","journal-title":"Biochim. Et. Biophys. Acta (BBA) Bioenerg."},{"key":"10.1016\/j.biopha.2025.118522_bib106","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10571-012-9892-5","article-title":"Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid","volume":"33","author":"Moraes","year":"2013","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118522_bib107","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0925-4439(01)00112-0","article-title":"Experimental hyperphenylalaninemia provokes oxidative stress in rat brain","volume":"1586","author":"Kienzle Hagen","year":"2002","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/0972-2327.104323","article-title":"Hippocampus in health and disease: an overview","volume":"15","author":"Anand","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.biopha.2025.118522_bib109","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10571-009-9455-6","article-title":"Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats","volume":"30","author":"Fernandes","year":"2010","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118522_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101204","article-title":"Gender- and age-dependencies of oxidative stress, as detected based on the steady state concentrations of different biomarkers in the MARK-AGE study","volume":"24","author":"Pinchuk","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1620\/tjem.213.261","article-title":"Aging-Related oxidative stress in healthy humans","volume":"213","author":"Mendoza-N\u00fa\u00f1ez","year":"2007","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.biopha.2025.118522_bib112","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1073\/pnas.63.4.1365","article-title":"Inhibition of human brain pyruvate kinase and hexokinase by phenylalanine and phenylpyruvate: possible relevance to phenylketonuric brain damage","volume":"63","author":"Weber","year":"1969","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118522_bib113","series-title":"Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease","first-page":"427","article-title":"Pyruvate dehydrogenase, pyruvate carboxylase, krebs cycle, and mitochondrial transport disorders","author":"Jakkamsetti","year":"2020"},{"key":"10.1016\/j.biopha.2025.118522_bib114","series-title":"Pediatric Critical Care","first-page":"1058","article-title":"Cellular respiration","author":"Zimmerman","year":"2011"},{"key":"10.1016\/j.biopha.2025.118522_bib115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0736-5748(02)00108-9","article-title":"Hyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats","volume":"21","author":"Costabeber","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118522_bib116","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.brainresbull.2008.02.035","article-title":"Functions and effects of creatine in the central nervous system","volume":"76","author":"Andres","year":"2008","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.biopha.2025.118522_bib117","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/life11050425","article-title":"Creatine levels in patients with phenylketonuria and mild hyperphenylalaninemia: a pilot study","volume":"11","author":"Verduci","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.biopha.2025.118522_bib118","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.neuron.2019.07.009","article-title":"Development and arealization of the cerebral cortex","volume":"103","author":"Cadwell","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2025.118522_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.1997.tb00294.x","article-title":"Changes in cerebral glucose metabolism with normal aging","volume":"4","author":"Blesa","year":"1997","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.biopha.2025.118522_bib120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jcbfm.2009.197","article-title":"Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy","volume":"30","author":"Boumezbeur","year":"2010","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib121","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10545-013-9650-y","article-title":"Tract-based evaluation of White matter damage in individuals with early-treated phenylketonuria","volume":"37","author":"Peng","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib122","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2013.03.020","article-title":"White matter integrity and executive abilities in individuals with phenylketonuria","volume":"109","author":"Antenor-Dorsey","year":"2013","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib123","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13023-018-0912-5","article-title":"White matter microstructural damage in early treated phenylketonuric patients","volume":"13","author":"Gonz\u00e1lez","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib124","doi-asserted-by":"crossref","unstructured":"Hood, A., Rutlin, J., Shimony, J.S., Grange, D.K. & White, D.A. Brain White Matter Integrity Mediates the Relationship Between Phenylalanine Control and Executive Abilities in Children with Phenylketonuria. in 41\u201347 (2016). doi:10.1007\/8904_2016_579.","DOI":"10.1007\/8904_2016_579"},{"key":"10.1016\/j.biopha.2025.118522_bib125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1152\/jn.00221.2016","article-title":"White matter and cognition: making the connection","volume":"116","author":"Filley","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.biopha.2025.118522_bib126","article-title":"White matter tract microstructure, macrostructure, and associated cortical gray matter morphology across the lifespan","author":"Schilling","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.biopha.2025.118522_bib127","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jnr.24598","article-title":"White matter disturbances in phenylketonuria: possible underlying mechanisms","volume":"99","author":"Ferreira","year":"2021","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","article-title":"Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?","volume":"61","author":"Shefer","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib129","doi-asserted-by":"crossref","first-page":"43000","DOI":"10.1038\/srep43000","article-title":"Oxygen impairs oligodendroglial development via oxidative stress and reduced expression of HIF-1\u03b1","volume":"7","author":"Brill","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118522_bib130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2018.01.018","article-title":"Protective effects of a radical scavenger edaravone on oligodendrocyte precursor cells against oxidative stress","volume":"668","author":"Takase","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2025.118522_bib131","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2016.02.004","article-title":"Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria","volume":"118","author":"Christ","year":"2016","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.biopha.2025.118522_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101916","article-title":"White and gray matter brain development in children and young adults with phenylketonuria","volume":"23","author":"Hawks","year":"2019","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.biopha.2025.118522_bib133","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jimd.12561","article-title":"Cortical thickness and its relationship to cognitive performance and metabolic control in adults with phenylketonuria","volume":"45","author":"Muri","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib134","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11689-024-09553-w","article-title":"Volumetric brain reductions in adult patients with phenylketonuria and their relationship with blood phenylalanine levels","volume":"16","author":"Pardo","year":"2024","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.biopha.2025.118522_bib135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jimd.12065","article-title":"The neurological and psychological phenotype of adult patients with early-treated phenylketonuria: a systematic review","volume":"42","author":"Burlina","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib136","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12883-022-02946-1","article-title":"Mild hyperphenylalaninemia (hpa) presenting as orthostatic tremor: a case report","volume":"22","author":"Li","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2025.118522_bib137","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.parkreldis.2021.06.011","article-title":"The neurological and neuropsychiatric spectrum of adults with late-treated phenylketonuria","volume":"89","author":"Mainka","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.biopha.2025.118522_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00561","article-title":"Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments","volume":"10","author":"Ashe","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopha.2025.118522_bib139","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s13023-021-02138-z","article-title":"Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre","volume":"16","author":"Altman","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib140","doi-asserted-by":"crossref","unstructured":"Velema, M., Boot, E., Engelen, M. & Hollak, C. Parkinsonism in Phenylketonuria: A Consequence of Dopamine Depletion? in 35\u201338 (2014). doi:10.1007\/8904_2014_386.","DOI":"10.1007\/8904_2014_386"},{"key":"10.1016\/j.biopha.2025.118522_bib141","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-012-9548-0","article-title":"Chronic kidney disease in adolescent and adult patients with phenylketonuria","volume":"36","author":"Hennermann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib142","doi-asserted-by":"crossref","first-page":"1693S","DOI":"10.1093\/jn\/137.6.1693S","article-title":"Adverse gastrointestinal effects of arginine and related amino acids","volume":"137","author":"Grimble","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2025.118522_bib143","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1158\/1078-0432.CCR-06-2076","article-title":"DNA methylation as a therapeutic target in cancer","volume":"13","author":"Issa","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118522_bib144","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","article-title":"Targeting DNA methylation for epigenetic therapy","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118522_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111829","article-title":"Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells","volume":"186","author":"Pechalrieu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118522_bib146","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2025.118522_bib147","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tibtech.2014.09.002","article-title":"Drug target miRNAs: chances and challenges","volume":"32","author":"Schmidt","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biopha.2025.118522_bib148","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ntt.2017.12.002","article-title":"Epigenetic mechanisms in developmental neurotoxicity","volume":"66","author":"Raciti","year":"2018","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.biopha.2025.118522_bib149","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000504669","article-title":"The role of MicroRNAs in influencing body growth and development","volume":"93","author":"Cirillo","year":"2020","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.biopha.2025.118522_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1569548","article-title":"Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation","volume":"15","author":"Kawata","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118522_bib151","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fpsyt.2019.00808","article-title":"Epigenetic modifications in stress response genes associated with childhood trauma","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.biopha.2025.118522_bib152","unstructured":"U.S. Food & Drug Administration. Ethical Considerations for Clinical Investigations of Medical Products Involving Children. \u3008https:\/\/www.fda.gov\/media\/161740\/download\u3009 (2022)."},{"key":"10.1016\/j.biopha.2025.118522_bib153","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2025.118522_bib154","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2891-12-142","article-title":"Effects of coenzyme Q10 supplementation (300 mg\/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial","volume":"12","author":"Lee","year":"2013","journal-title":"Nutr. J."},{"key":"10.1016\/j.biopha.2025.118522_bib155","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s11011-019-00472-7","article-title":"Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria","volume":"34","author":"Bortoluzzi","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib156","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s11064-014-1353-8","article-title":"Co-administration of creatine plus pyruvate prevents the effects of phenylalanine administration to female rats during pregnancy and lactation on enzymes activity of energy metabolism in cerebral cortex and hippocampus of the offspring","volume":"39","author":"Bortoluzzi","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2025.118522_bib157","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11011-011-9271-9","article-title":"Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats","volume":"27","author":"Berti","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2025.118522_bib158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2007.02.002","article-title":"The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study","volume":"91","author":"Schindeler","year":"2007","journal-title":"Mol. Genet. Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:35:39Z","timestamp":1772829339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":158,"alternative-id":["S0753332225007164"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118522","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylketonuria: A guide through the complex maze of its neurological pathophysiology providing a new perspective on treatment strategies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118522"}}